Varivax (Varicella virus) vaccine schedule

A live attenuated vaccination called Varivax (Varicella Virus Vaccine) promotes active protection against the varicella virus. It is used in the prevention of varicella (Chickenpox) in the following group of patients:

  • For the prevention of varicella in persons aged 1 year and older
  • All kids, teens, and adults who don't exhibit immunity are advised to get vaccinated, according to the Advisory Committee on Immunization Practices (ACIP).
  • Vaccination is especially required for:
    • Adolescents and adults in households with children
    • Household contacts of immunocompromised patients
    • Persons in environments where transmission has been previously reported
    • People who reside or work in places where transmission is quite likely, such as childcare providers, instructors, residents, and institutional employees
    • Nonpregnant women of childbearing age
    • International travelers
    • Health care people
  • It is laso used as off-label medicine in postexposure prophylaxis of varicella

Varivax Dose in Adults

Varivax dosage in the treatment of Varicella immunization:

    • Two doses are given of 0.5 mL separated by ≥ 1 month (1-2 months apart).
  • All children and adults without proof of immunity are advised to receive two doses of the vaccine, according to the ACIP.
  • People who received only one dose of a varicella vaccine should receive a second dose.
  • Canadian labeling:
    • 2 separate dosages 0.5 mL are administered 4 to 8 weeks apart (Varivax III) or after 6 weeks.
  • Adults and adolescents who have only had one dose of the vaccine are advised to get a second dose, according to the NACI.

Off Label Dosage in the Postexposure prophylaxis of healthy, previously unvaccinated individuals:

  • It is best to provide 0.5 mL subQ within 3 days of exposure, albeit this can happen up to 5 days later.

Varivax Dose in Childrens

Varivax dose in the treatment of Primary immunization:

  • CDC and ACIP recommendations:
    • Children ≥12 months:
      • It is given as 0.5 mL subQ per dose for a total of 2 doses administered as:
        • 12 - 15 months of age and 4 - 6 years of age.
      • If more than three months have gone since the first treatment, the second dose may be given sooner.
      • It is regarded as valid if the second dose is administered four weeks following the first dose.
  • Canadian labeling:
      • Children:
        • Varilrix:
          • 2 doses of 0.5 mL S/C separated by ≥6 weeks
        • Varivax III:
          • 0.5 mL S/C as a single dose
      • Adolescents:
        • SubQ:
          • 2 doses  0.5 mL S/C given separated by 4 to 8 weeks (Varivax III) or ≥6 weeks (Varilrix)

Varivax dose in the treatment of Catch-up immunization:

  • Children and Adolescents:
    • ACIP recommendations: Series should not be restarted.
      • 0.5 mL subQ per dose is given for a total of 2 doses administered as follows:
        • first dose administered on the chosen day
        • If the patient is younger than 13 years old, the second dose is typically administered at least 3 months or at least 1 month following the first dose (if age is more than 13 years).

Varivax dose in the postexposure prophylaxis of healthy, previously unvaccinated individuals:

  • Children older than 12 months and Adolescents:
    • Ideally, 0.5 mL subQ should be administered within 72 hours of exposure, however it is possible to use it up to 120 hours later.

Pregnancy Risk Factor: D

  • Pregnancy should be avoided for three months after receiving the varicella virus vaccination, which is contraindicated for females.
  • These women's miscarriage and birth defect rates did not appear to be higher than background levels.
  • Additionally, there were no newborns born with anomalies suggestive with congenital varicella syndrome.
  • Congenital varicella syndrome can result from varicella infection in the first or second trimester.
  • The newborn can contract varicella if the mother contracts it starting five days before delivery and lasting until two days after delivery.
  • During a prenatal checkup, all women should be examined for immunity; those who don't show any signs of immunity should be immunised following the completion or termination of pregnancy.

Varivax vaccine use during breastfeeding:

  • Status of varicella is nor known in breast milk.
  • The decision to breastfeed after an immunization should take into account the chance of infant exposure, the effects of breastfeeding to the infant, and benefits of treatment to the mother.
  • Guidelines recommend that immunization should not be delayed due to breastfeeding and vaccinated women may continue breastfeeding.
  • Breastfed infants should be vaccinated as recommended schedules.

Varivax Dose in Renal Disease:

  • There are no dosage adjustments given in the manufacturer's labeling in patients with renal disease.

Varivax Dose in Liver Disease:

  • There are no dosage adjustments given in the manufacturer's labeling.in patients with liver disease.

Common Side Effects of Varivax vaccine include:

  • Local:
    • Injection site reaction includes
      • Swelling
      • Pain
      • Hematoma
      • Numbness
      • Stiffness
      • Induration
      • Erythema
  • Miscellaneous:
    • Fever

Less Common Side Effects of Varivax Vaccine Include:

  • Central Nervous System:
    • Irritability
    • Fatigue
    • Nervousness
    • Headache
    • Malaise
    • Sleep Disturbance
    • Chills
  • Dermatologic:
    • Diaper Rash
    • Skin Rash
    • Contact Dermatitis
    • Urticaria
    • Dermatitis
    • Eczema
    • Pruritus
    • Miliaria
    • Xeroderma
    • Varicella-Like Rash
  • Gastrointestinal:
    • Constipation
    • Anorexia'
    • Nausea
    • Aphthous Stomatitis
    • Dental Discomfort
    • Vomiting
    • Abdominal Pain
    • Diarrhea
  • Genitourinary:
    • Hematologic & Oncologic: Lymphadenopathy
    • Herpes Labialis
  • Hypersensitivity:
    • Hypersensitivity Reaction
  • Neuromuscular & Skeletal:
    • Neck Stiffness
    • Myalgia
    • Arthralgia
  • Ophthalmic:
    • Eye Discomfort
  • Otic:
    • Otitis
  • Respiratory:
    • Respiratory Tract Disease (Lower/Upper)
    • Cough

Contraindication to Varivax Vaccine Include:

  • Patients with AIDs or other clinical signs of HIV
  • Having primary and acquired immunodeficiency states;
  • active & untreated tuberculosis
  • severe allergic reaction involving the vaccine, gelatin, neomycin, or any other formulation component
  • Individuals with compromised immune systems, immunosuppressed patients, including those with lymphomas, leukaemia, or other malignant
  • neoplasms that affect the lymphatic or bone marrow systems (including immunosuppressive doses of corticosteroids)
  • Suffering from febrile illness
  • Pregnant

Warnings & Precautions

  • Anaphylactoid/ Allergic reactions:
    • Epinephrine 1 mg/mL for anaphylactoid and hypersensitivity responses should be available when using the vaccination.
  • CNS infection:
    • Immunocompetent people who had previously received the varicella virus vaccine have experienced cases of meningitis and encephalitis caused by the vaccine strain of the virus months to years after vaccination.
    • Cases frequently include an existing or recent herpes zoster rash.
  • Syncope:
    • Utilization of injectable vaccines has been associated with syncope, which can result in severe secondary injuries such skull fracture and brain bleeding.
    • If syncope occurs, actions should be taken to restore cerebral perfusion and prevent injury from falls.
  • Acute illness:
    • Although the manufacturer states that fever is a contraindication, current recommendations allow vaccination delivery to people with mild acute illnesses.
  • Altered immunocompetence:
    • Immunodeficient or immunosuppressed individuals should not use this vaccination.
    • Near family and friends of immunocompromised people can get the majority of age-appropriate immunizations.
    • When possible, live vaccinations should be administered up to 4 weeks before immunosuppression and prevented within 2 weeks of immunosuppression.
    • After receiving immunosuppressive therapy, live vaccinations shouldn't be administered for at least 3 months.
  • HIV:
    • HIV-infected children who have CD4+ T lymphocyte percentages above 15% for their age can receive live attenuated varicella vaccine.
    • Children above the age of 8, teenagers, and adults with CD4+ T-lymphocyte counts under 200 cells per microliter are eligible for vaccination.

Monitor:

  • Keep an eye out for allergy symptoms like rash and fever.
    15 minutes after injection, keep an eye out for syncope and allergic responses.
  • Maintain the patient in a supine or Trendelenburg position if seizure-like activity accompanied by syncope occurs in order to restore appropriate cerebral perfusion.

How to administer Varivax vaccine?

SubQ:

  • Inject in the lateral or anterior portion of the upper thigh.
  • Give intramuscularly or intravenously not.
  • Give right away after reconstitution.
  • Only administer Varilrix (a Canadian medication) to the deltoid area.
  • It shouldn't be combined with other injections or immunizations.
  • For each injection, separate needles and syringes should be used.
  • By administering the shot while seated or lying down, syncope-related risks can be avoided.
     

Mechanism of action of Varivax (Varicella virus) vaccine:

  • It is a live attenuated vaccine.
  • By triggering cell-mediated and humoral immune reactions, it provides active immunisation against the varicella-zoster virus, which is the cause of Chickenpox.

The onset of action:

  • After a single treatment and two doses, the rates of séroconversion after 4–6 weeks are 97% and 99.9%, respectively.
  • The seroconversion rate was around 75% after 4 weeks of the first dosage and 99% after 4 weeks of the second dose in adults and adolescents older than 13 years old.

Duration of action:

  • Antibody titers can be found 10 years after vaccination.
  • The antibody titers may vary by year and age group, but for children at ten years and for adults and adolescents at six years post-immunization, they range from 99% to 100%.
  • The wild type of varicella may increase antibody levels.

International Brands of VAR:

  • Okavax
  • V-Z Vax
  • Vaccin Varilrix
  • Varcelvax
  • Varicela Biken
  • Varilrix
  • Varipox
  • Varivax

Varicella Virus Vaccine in Pakistan:

  • Okavax - Sanofi Aventis
  • Varilrix - GSK
  • Varivac - Changchun Changsheng Life Sciences/Hi-Warble
  • Vaxapox - Sind Medical stores

Comments

NO Comments Found